Core Viewpoint - Rosen Law Firm is reminding investors who purchased NAPCO Security Technologies, Inc. securities during the specified Class Period of the upcoming lead plaintiff deadline on June 24, 2025 [1]. Group 1: Class Action Details - Investors who bought NAPCO securities between February 5, 2024, and February 3, 2025, may be eligible for compensation without any out-of-pocket fees through a contingency fee arrangement [2]. - A class action lawsuit has already been filed, and interested parties must move the Court to serve as lead plaintiff by June 24, 2025 [3]. - The Rosen Law Firm emphasizes the importance of selecting qualified legal counsel with a successful track record in securities class actions [4]. Group 2: Case Allegations - The lawsuit alleges that NAPCO made false and misleading statements regarding its revenue outlook and growth potential, downplaying risks associated with seasonality and macroeconomic factors [5]. - It is claimed that NAPCO's optimistic margin growth goals and reassurances about hardware sales did not align with reality, as the company was unable to accurately forecast product demand [5].

Core Insights - Advanced Micro Devices (AMD) shares are currently overvalued with a Value Score of D, trading at a forward 12-month Price/Sales ratio of 5.63X compared to the industry's 3.60X [1][3] Stock Performance - AMD shares have declined by 3.9% year-to-date, underperforming the Zacks Computer and Technology sector's increase of 2.5% and the Zacks Computer – Integrated Systems industry's growth of 16.4% [3][5] - The underperformance is attributed to macroeconomic challenges, including higher tariffs and export controls on certain Instinct GPUs to China [3] AI Market Expansion - AMD is enhancing its presence in the AI market with the introduction of the Instinct MI350 Series GPUs, which offer 4x generational AI compute gains [7] - Strategic partnerships with companies like Meta Platforms, OpenAI, Microsoft, and Oracle are pivotal in supporting AMD's role in next-gen AI workloads [8][10] EPYC Processor Adoption - The adoption of AMD's fifth-gen EPYC Turin processors is significant, with deployment across top telecom, aerospace, and semiconductor companies [12] - Nokia has adopted AMD's fifth-gen EPYC 9005 Series processors for its Cloud Platform, improving performance for 5G applications [13] Acquisitions and Market Position - AMD's acquisition of ZT Systems aims to strengthen its AI ecosystem and compete with NVIDIA in the AI chip market, targeting the $500 billion data center AI accelerator market by 2028 [14] - Despite a strong portfolio, AMD faces challenges from export restrictions to China and competition from NVIDIA [15][18] Financial Guidance - AMD expects second-quarter 2025 revenues of $7.4 billion, reflecting a year-over-year growth of approximately 27%, but anticipates a $700 million reduction due to halted shipments to China [15][16] - The Zacks Consensus Estimate for AMD's second-quarter 2025 earnings is 56 cents per share, indicating a year-over-year decline of 18.84% [16] Conclusion - AMD's expanding portfolio and strategic partnerships are expected to enhance top-line growth, but near-term prospects are hindered by macroeconomic uncertainties and competition, particularly from NVIDIA [17][18]

Have you been paying attention to shares of Veeva Systems (VEEV) ? Shares have been on the move with the stock up 16.8% over the past month. The stock hit a new 52-week high of $291.69 in the previous session. Veeva Systems has gained 34.2% since the start of the year compared to the -1.5% move for the Zacks Medical sector and the 27.2% return for the Zacks Medical Info Systems industry.What's Driving the Outperformance?The stock has a great record of positive earnings surprises, as it hasn't missed our ear ...

Micron (MU) is one of the stocks most watched by Zacks.com visitors lately. So, it might be a good idea to review some of the factors that might affect the near-term performance of the stock.Shares of this chipmaker have returned +21.7% over the past month versus the Zacks S&P 500 composite's +3.6% change. The Zacks Computer - Integrated Systems industry, to which Micron belongs, has gained 13.5% over this period. Now the key question is: Where could the stock be headed in the near term?Although media repor ...

Group 1 - The stock of Inspire Medical Systems, Inc. (INSP) is experiencing significant attention due to high implied volatility in the options market, particularly for the Jan. 16, 2026 $95 Call option [1] - Implied volatility indicates the market's expectation of future price movement, suggesting that investors anticipate a significant change in the stock's price, potentially due to an upcoming event [2] - Inspire Medical Systems holds a Zacks Rank 3 (Hold) in the Medical Info Systems industry, which is in the top 33% of the Zacks Industry Rank, but analysts have lowered earnings estimates for the current quarter from 41 cents per share to 22 cents [3] Group 2 - The high implied volatility for Inspire Medical Systems may indicate a developing trading opportunity, as options traders often seek to sell premium on options with high implied volatility to capture decay [4]

Train Technologies is reaching milestones with its stock price soaring to all-time highs and the company reaching a market cap of more than 94 billion dollars. It's the latest focus of our new series, The Y behind the high, where we're taking a look at companies whose stock is at or near record highs. Train is among them with its business focused on sustainable solutions for commercial climate and HVAC systems.Train Technologies chairman and CEO Dave Ragnary joins us now. Dave, it's great to see you again. ...

Core Viewpoint - Daktronics, Inc. will release its fourth quarter and fiscal 2025 financial results on June 25, 2025, before market opening, followed by a conference call at 10:00 AM CT [1][2] Company Overview - Daktronics is the world's largest supplier of large-screen video displays, electronic scoreboards, LED text and graphics displays, and related control systems [5] - The company operates in four domestic business units: Live Events, Commercial, High School Park and Recreation, and Transportation, along with one International business unit [5] Conference Call Details - The conference call will be hosted by Interim CEO Brad Wiemann and Acting CFO Howard Atkins, featuring forward-looking statements and material information [2] - Participants must pre-register to access the call, receiving dial-in information and a PIN for entry [3][4] - The call will be accessible via phone or webcast, with a recording available for later replay [4]

SOUTHAMPTON, Pa., June 09, 2025 (GLOBE NEWSWIRE) -- Environmental Tectonics Corporation (OTC Pink: ETCC) (“ETC” or the “Company”) today reported its financial results for the fourteen week period ended February 28, 2025 (the “2025 fiscal fourth quarter”) and the fifty-three week period ended February 28, 2025 (“fiscal 2025”). Robert L. Laurent, Jr., ETC’s Chief Executive Officer and President stated, “Our strong backlog and pipeline of opportunities once again translated into increases in net sales, gross p ...

Core Insights - Tempus AI (TEM) experienced a 12.5% surge in early June, significantly outperforming the broader market due to positive investor reactions to new product launches [1][9] - The company has established a $200 million partnership with AstraZeneca and Pathos to develop a large oncology-focused foundation model, enhancing its position in AI-driven drug discovery [5][9] - Despite revenue growth, Tempus remains unprofitable, reporting an adjusted EBITDA loss of $16.2 million in Q1 2025, although this is an improvement from the previous year [14][16] Strategic Product Innovation - The xM Liquid Biopsy Assay utilizes whole-genome sequencing and fragmentomics for noninvasive monitoring of immunotherapy responses in advanced cancer patients, providing real-time treatment insights [3] - Tempus One, an AI-powered clinical assistant, has been integrated into major EHR systems, offering real-time, patient-specific insights to enhance clinical decision-making [4] Financial Performance - Year-to-date, TEM stock has increased by 83.8%, outperforming the Medical Info Systems industry and the S&P 500 [7] - The stock is currently trading at a forward 12-month price-to-sales (P/S) ratio of 7.77, which is above the industry average of 6.09, indicating it may be overvalued compared to peers [15][16] Recent Developments - The acquisition of Deep 6 AI enhances Tempus's clinical trial matching and provider analytics capabilities, expanding its provider connectivity to over 4,000 connections [6] - The partnership with AstraZeneca is expected to leverage over 300 petabytes of data, aiming to accelerate AI-driven drug discovery and diagnostics [5]

WOOD DALE, Ill., June 09, 2025 (GLOBE NEWSWIRE) -- Power Solutions International, Inc. (the “Company” or “PSI”) (Nasdaq: PSIX), a leader in the design, engineering and manufacture of emission-certified engines and power systems, announced today that it has been tentatively named to the Russell 3000®, Russell 2000® and Russell Microcap® indexes, according to a preliminary list of additions posted by FTSE Russell on June 6. Final inclusion is expected to take effect after the U.S. market opens on June 30, 202 ...